Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

Characterization of the role of LRRTMs in synaptic plasticity and memory formation

Project Overview

The key neuropathology underlying ASDs is abnormal neuronal communication as a result of altered synapse formation, function and plasticity. Specialized synaptic proteins known as cell adhesion molecules (CAMs) critically regulate synapse formation during brain development. CAMs known as Leucine Rich-Repeat TransMembrane neuronal proteins (LRRTMs), have recently been identified in screens for novel synapse promoting molecules. LRRTMs are highly synaptogenic, are located postsynaptically on glutamatergic synapses, and interact with presynaptic neurexins (Siddiqui et al., 2011). To date, Neurexin genes are the most strongly linked gene variants associated with ASDs (Sudhof et al., 2008). Given that multiple LRRTMs and neurexin gene variants are implicated in autism and intellectual disability and the lack of effective treatments for these disorders, it is crucially important that we understand the roles of LRRTMs in nervous system function. We generated LRRTM1 and LRRTM2 double knockout (DKO) mice models with the overall goal of determining how LRRTMs regulate synaptic transmission, plasticity and cognitive function. This project is highly novel as no constitutive model of dual LRRTM1/2 KO has yet been tested to determine if LRRTMs modulate synaptic function or memory. Due to the high expression profile of LRRTM1/2 (Lauren et al., 2003) and its role in memory formation, all experiments will be conducted in mouse hippocampus, subregion CA1. The following fundamental questions will be addressed using the DKO model: 1) What are the effects of LRRTM1/2 DKO on synaptic physiology and plasticity in the hippocampus 2) Do LRRTMs play a role in mediating synaptic organization and morphology? 3) Are synaptic proteomic profiles changed in the absence of LRRTM1/2? 4) Is memory performance altered in LRRTM1/2 DKOs?

Principal Investigator

Steven Connor , University of British Columbia

Partners and Donors

Bell Canada

Project Complete

Characterization of the role of LRRTMs in synaptic plasticity and memory formation

  • Grant Type

    Capacity building grants

  • Area of research

    Central Nervous System

  • Disease Area

    Autism

  • Competition

    Bell Mental Health Research Training Awards

  • Province

    British Columbia

  • Start Date

    2013

  • Total Grant Amount

    $165,000

  • Health Canada Contribution

    $82,500

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2025 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co

  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds
Project Directory
Donate Now